What is its status?
Read what the selected regulatory and other official records support, and when those sources were checked.
Find cited status →Public beta · Selective source coverage
Peptide records.
Without the hype.
Find a peptide’s research, trial registrations, and regulatory records. Read an evidence review or open the original sources.
Explore 2,747 cited source records. Browse the archive → · Sources and coverage →
Start with your question
Find the evidence that matters to your question.
Choose a peptide, then go straight to its cited status, reviewed human evidence, or collection history. Each answer keeps its sources, dates, and uncertainty visible.
What do human studies say?
Explore human evidence reviews and the publications and trial records behind each profile.
Explore human evidence →What changed in the collection?
Separate newly added records, revised conclusions, and corrections. A new addition is not automatically a new finding.
Inspect collection history →Working across the evidence? Open the research atlas, browse Human Evidence Reviews, or inspect the FDA compounding tracker.
Recent highlights
What changed recently
Start with a few recent published changes across studies, reviews, and official-source notes. Site additions, source dates, review dates, and source checks remain separate so a recent entry does not imply a new appraisal. See the full collection → Browse source records →
Study context updated
NCT01394952: REWIND: cardiovascular outcomes
Time to the first cardiovascular death, nonfatal heart attack or nonfatal stroke.
Read study →Human Evidence Review updated
Cagrilintide Human Evidence Review
The selected cagrilintide-alone study reported weight reduction. Later combination trials reported weight or glycemic improvements, but their results cannot be attributed to cagrilintide alone. Gastrointestinal adverse events were common, and a correction to REIMAGINE 2 remains to be reconciled.
Read review →Official-source note updated
BPC-157 official-source note
Selected FDA advisory-briefing sections, not a final agency ruling. The source date identifies the committee meeting (July 23–24 for the 2026 packages), not a new approval or final decision.
Read source note →Sources: [1]
Citable by design
Take the sources with you.
Every story has a versioned evidence object with source pins and correction history. Build an evidence pack, open the agent navigation index, or check coverage and gaps.
Our standard
“Report what the source says—then show the source.”
PeptideScanner separates regulatory records, trial registrations, and company or institutional statements from established scientific truth. If something is unclear, we label the uncertainty or leave it unpublished.
Read our methodology